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Recent data suggests that catecholamine systems might have a trophic role in the 
spinal cord. These data are based on the clinical evidence that beta-2 agonists pro-
duce a relief in spinal motor neuron disorders.
Therefore, in the present study we isolated ventral spinal cord cell cultures and 
we administered either the beta-2 agonist salbutamol alone or in combination with 
the beta-2 antagonist butoxamine. These experiments were carried out both in 
baseline conditions and in the presence of a non-NMDA glutamate shock. In fact, 
increased extracellular glutamate concentration can be toxic for neuronal cells. Glu-
tamate-mediated excitotoxicity relies on the stimulation of both NMDA and non-
NMDA receptors although naturally occurring motor neuron loss is thought to 
depend on an excess of stimulation of non-NMDA receptors. Therefore, primary cell 
cultures obtained from the ventral spinal cord of 14-days-old mice embryos were pre-
administered MK-801, a non-competitive antagonist of NMDA receptors, immediately 
before the non-NMDA (both kainate and AMPA) receptor agonist kainic acid (KA, 50 
and 100 µM for 15 min) either in baseline conditions or in combination with salbu-
tamol (10 µM) and butoxamine (50 µM) administered 30 min before KA. We found 
that the beta-2 antagonist butoxamine did not produce any effect either alone or in 
combination with kainate. Although butoxamine prevented the effects induced by the 
beta-2 agonist salbutamol. In particular, salbutamol prevented non-NMDA-induced 
motor neuron loss and this effect was abolished by the concomitant administration 
of butoxamine. When salbutamol was administered alone we detected morphologi-
cal changes at motor neuron level. We also analysed whether salbutamol administra-
tion increased the expression of survival motor neuron protein (SMN, an endogenous 
molecule which provides protective effect for motor neurons) as a possible mecha-
nism of neuroprotection. Unexpectedly, the protective effects induced by salbutamol 
were accompanied by a reduction of the SMN, while KA induced an increase in SMN 
levels. These results lend substance that catecholamine receptors subtype beta-2 pro-
tect motor neurons in the short term following glutamate excitotoxicity. It is likely 
that the paradoxical effects observed for SMN level might be due to the need of a 
compensatory mechanism (following NMDA) or the reduced level of neuronal stress 
(following salbutamol). Further studies are in progress to unravel the mechanisms 
responsible for neuroprotection induced at motor neuron level by catecholamine and 
beta-2 receptors.
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